Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Listent Medical Tech has developed and commercialized several generations of cochlear implant systems. The company's LCI series of cochlear implants have received regulatory approval in China, with the latest generation LCI‑20PI launched after seven years of R&D. Their products are recognized as having reached international advanced levels for performance. The company broke the foreign monopoly on this technology within China and was first to receive domestic registration certification for a Chinese-made cochlear implant.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Listent Medical Tech.